TABLE 1.
Antagonist | Acronym | IC50 (mM) |
---|---|---|
6-Thioguanosine | 6-TG | 1.00 |
6-Chloroguanosine | 6-CG | 0.89 |
6-Benzylthioinosine | 6-BTI | 0.05 |
6-Methylmercaptopurine riboside | 6-MMPR | 0.32 |
6-O-Methylguanosine | 6-OMG | 0.35 |
2-Aminoadenosine | 2-AADE | 0.70 |
Xanthosine | XAN | 7.19 |
6-Methylaminopurine riboside | 6-MAPR | 0.19 |
2-Aminopurine riboside | 2-APR | 0.38 |
Ribofuranosyl-((9H-purin-6-yl) piperazin-1-yl)ethanone | 6-PPER | 0.05 |
6-N-Benzylmethyladenosine | 6-BMA | 0.12 |
6-N-Benzylaminopurine | 6-BAP | 1.55 |
6-(γ,γ-Dimethylallyl amino)purine riboside | 6-DMAA | 0.36 |
6-N-Benzoyladenosine | 6-NBA | 1.14 |
6-N-Piperidineadenosine | 6-PPA | 1.09 |
6-N-Diethyladenosine | 6-DEA | 0.31 |
6-N-Dipropyladenosine | 6-DPA | 0.76 |
6-N-((3-Ethylacetyl)cyclohexyl) adenosine | 6-ECA | 0.70 |
d-Alanine | d-Ala | 0.02 |
Spore suspensions were individually supplemented with various concentration of compounds II to XLVI and then treated with 250 μM inosine and 40 μM l-alanine. Compounds that did not inhibit germination are not shown in this table.